Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ANI Pharmaceuticals Inc

ANIP
Current price
59.19 USD -0.35 USD (-0.59%)
Last closed 59.81 USD
ISIN US00182C1036
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 184 563 200 USD
Yield for 12 month +5.51 %
1Y
3Y
5Y
10Y
15Y
ANIP
21.11.2021 - 28.11.2021

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. Address: 210 Main Street West, Baudette, MN, United States, 56623

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

78.67 USD

P/E ratio

Dividend Yield

Current Year

+486 816 000 USD

Last Year

+316 385 000 USD

Current Quarter

+148 332 000 USD

Last Quarter

+138 040 000 USD

Current Year

+305 303 000 USD

Last Year

+177 600 000 USD

Current Quarter

+85 257 000 USD

Last Quarter

+65 645 000 USD

Key Figures ANIP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 82 125 000 USD
Operating Margin TTM -7.34 %
PE Ratio
Return On Assets TTM 1.25 %
PEG Ratio 1.06
Return On Equity TTM -1.60 %
Wall Street Target Price 78.67 USD
Revenue TTM 555 456 000 USD
Book Value 20.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.50 %
Dividend Yield
Gross Profit TTM 177 600 000 USD
Earnings per share -0.47 USD
Diluted Eps TTM -0.47 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 1 382.40 %
Profit Margin -1.28 %

Dividend Analytics ANIP

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ANIP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:6
Payout Ratio
Last Split Date 18.07.2013
Dividend Date
Consecutive Years
Consistent Years
Continuous Dividends

Stock Valuation ANIP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 9.14
Enterprise Value Revenue 3.04
Price Sales TTM 2.13
Enterprise Value EBITDA 24.04
Price Book MRQ 2.93

Financials ANIP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ANIP

For 52 weeks

52.00 USD 70.81 USD
50 Day MA 57.98 USD
Shares Short Prior Month 2 111 003
200 Day MA 62.09 USD
Short Ratio 6.56
Shares Short 1 839 789
Short Percent 11.34 %